Trial intelligence / Profile preview

Tolcapone Effects on Vigilance After Sleep Deprivation

NCT02080715Phase 1Completed

Sponsor
University of Zurich
Start
Jun 2013
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in sleep deprivation comparing Tolcapone with Placebo (2 arms). Primary endpoint: Evolution of vigilance during prolonged wakefulness at 2 weeks. Started Jun 2013; status: completed.

02

Drugs

tolcapone
03

Conditions

sleep deprivation

Beyond the preview

Go deeper on NCT02080715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02080715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call